Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersBARRIL, G; QUIROGA, J. A; SANZ, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 37-44, issn 0269-2813, 8 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Interferon alfa-2a therapy for life-threatening hemangiomas of infancyEZEKOWITZ, R. A. B; MULLIKEN, J. B; FOLKMAN, J et al.The New England journal of medicine. 1992, Vol 326, Num 22, pp 1456-1463, issn 0028-4793Article

Human interferon-gamma increases adhesion of cultured carcinoma cells to the substratumMARTH, C; DAXENBICHLER, G; MAYER, I et al.Cancer letters. 1987, Vol 37, Num 1, pp 59-69, issn 0304-3835Article

Early Serum HBsAg Drop : A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative PatientsMOUCARI, Rami; MACKIEWICZ, Vincent; VALLA, Dominique et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1151-1157, issn 0270-9139, 7 p.Article

Nonsurgical treatments for skin cancer: retinoids and 2-interferonLIPPMAN, S. M; SHIMM, D. S; MEYSKENS, F. L. JR et al.The Journal of dermatologic surgery and oncology. 1988, Vol 14, Num 8, pp 862-869, issn 0148-0812Article

Traitement de la leucémie myéloïde chronique par interféron alpha recombinant et hydroxyurée = Treatment of chronic myelocytic leukaemia with recombinant alpha interferon and hydroxyureaGUILHOT, F; TANZER, J; BRIZARD, A et al.La Presse médicale (1983). 1988, Vol 17, Num 29, issn 0755-4982, 1494Article

Alpha-interferon therapy for essential thrombocythaemiaGILES, F. J; GRAY, A. G; HOFFBRAND, A. V et al.Lancet (British edition). 1988, Vol 2, Num 8602, pp 70-72, issn 0140-6736Article

In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferonSAMUELS, B. L; GOLOMB, H. M; BROWNSTEIN, B. H et al.Blood. 1987, Vol 69, Num 6, pp 1570-1573, issn 0006-4971Article

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis CBREHM CHRISTENSEN, Peer; BYGUM KRARUP, Henrik; LUND LAURSEN, Alex et al.Scandinavian journal of gastroenterology. 2012, Vol 47, Num 8-9, pp 1115-1119, issn 0036-5521, 5 p.Article

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsGOWIN, Krisstina; THAPALIYA, Prakash; CAMORIANO, John et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1570-1573, issn 0390-6078, 4 p.Article

Long-term Efficacy and Safety of Low-Dose and Dose-Escalating Interferon Alfa-2a Therapy in Refractory Behçet UveitisONAL, Sumru; KAZOKOGLU, Haluk; KOC, Aylin et al.Archives of ophthalmology (1960). 2011, Vol 129, Num 3, pp 288-294, issn 0003-9950, 7 p.Article

Safety and Effectiveness of Interferon Alpha-2a in Treatment of Patients with Behçet's Uveitis Refractory to Conventional TreatmentsSOBACI, Güngör; ERDEM, Uzeyir; DURUKAN, A. Hakan et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 7, pp 1430-1435, issn 0161-6420, 6 p.Article

Interferon Alpha-2a Reduces Early Erythema After Full-Thickness Skin Graft in the PigJUN SIK KIM; SON, Daegu; HYUN HWANG, O et al.Dermatologic surgery. 2009, Vol 35, Num 10, pp 1514-1524, issn 1076-0512, 11 p.Article

Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon α2a (40 kDa; PEGASYS®)CHAN, Henry L.-Y; WONG, Vincent W.-S; CHIM, Angel M.-L et al.Antiviral therapy (London). 2008, Vol 13, Num 4, pp 555-562, issn 1359-6535, 8 p.Article

Interféron : IntronA®, Roféron® = Interferon : IntronA®, Roferon®GAUDY-MARQUESTE, C; GROB, J.-J.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 917-921, issn 0151-9638, 5 p.Article

Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomasEDMONSON, J. H; LONG, H. J; FRYTAK, S et al.Cancer treatment reports. 1987, Vol 71, Num 7-8, pp 747-748, issn 0361-5960Article

Penile Paraffinoma Developing During Treatment With Pegylated Interferon Alfa-2a for Chronic Hepatitis C Virus InfectionBACHMEYER, Claude; MOGUELET, Philippe; GOMBEAUD, Thierry et al.Archives of dermatology (1960). 2011, Vol 147, Num 10, pp 1232-1233, issn 0003-987X, 2 p.Article

HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2aLANGE, Christian M; SUSSER, Simone; HERRMANN, Eva et al.Scandinavian journal of gastroenterology. 2011, Vol 46, Num 11, pp 1362-1368, issn 0036-5521, 7 p.Article

RG7128 Alone or in Combination with Pegylated Interferon-α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected PatientsLE POGAM, Sophie; SESHAADRI, Amritha; NAJERA, Isabel et al.The Journal of infectious diseases. 2010, Vol 202, Num 10, pp 1510-1519, issn 0022-1899, 10 p.Article

Successful treatment of verruca plantaris with a single sublesional injection of interferon-α2aAKSAKAL, A. A; OZDEN, M. G; ATAHAN, C et al.Clinical and experimental dermatology (Print). 2009, Vol 34, Num 1, pp 16-19, issn 0307-6938, 4 p.Article

Randomized dose-escalation study evaluating peginterferon Alfa-2a in patients with metastatic malignant melanomaDUMMER, Reinhard; GARBE, Claus; THOMPSON, John A et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1188-1194, issn 0732-183X, 7 p.Article

Peginterferon Alfa-2a: A review of approved and investigational usesMATTHEWS, S. James; MCCOY, Christopher.Clinical therapeutics. 2004, Vol 26, Num 7, pp 991-1025, issn 0149-2918, 35 p.Article

Alfa-2a recombinant interferon in HIV associated thrombocytopeniaELLIS, M. E; NEAL, K. R; LEEN, C. L. S et al.British medical journal (1857). 1987, Vol 295, Num 6612, issn 0007-1447, 1519Article

Proceedings/ Interferon alfa-2a in cancer therapy, official satellite symposium, 14th international UICC cancer congress, Budapest, HUN, 22 Aust 1986International journal of cancer. 1987, issn 0020-7136, 45 p., suppl. 1Conference Proceedings